NEW YORK (AP) — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his 30s to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept back onto his 5-foot-5-inch frame.
A little over a year ago, the 58-year-old Manhattan resident went on a new weight loss drug called Wegovy. He’s lost 30 pounds, and has started eating healthier food and exercising — the habits behind many commercial diet plans and decades of conventional wisdom on sustainable weight loss.
Yet Jobling’s experience also has altered his perspective on dieting. He now sees obesity as a disease that requires medical intervention, not just behavioral changes. In fact, he thinks he will need to stay on a drug like Wegovy for the rest of his life even though it has taken some of the joy out of eating.
Storms damage homes in Oklahoma and Kansas. But in Houston, most power is restored
Number of foreign visitors to China sees significant rebound
Heart attack sees bus driver ram crowd, kill 3 pedestrians
Strictly star Giovanni Pernice's former partner Rose Ayling
EU unveils 'remedy' for migrants
China urges US to put ties back on track
Profile: President of Suriname Chandrikapersad Santokhi
Supreme Court declines to hear challenge to Maryland ban on rifles known as assault weapons
Comicomment: Who is behind the provocations in South China Sea
NBA playoffs: Edwards leads Wolves to 98
Number of foreign visitors to China sees significant rebound